At a glance
ClinicalIndex Comparison RecordN/ACompleted· 482 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Interventional Study on the Use of TachoSil® During Thyroid Surgery
In Brief
An observational study for Hemorrhage. Completed, enrolled 482 participants across 132 sites.
Detailed Summary
Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2008
Enrollment StartSep 2008
Primary CompletionJan 2009
TodayJul 2026
First PostedJun 18, 2008
Enrollment StartSep 1, 2008
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 18.0 years ago